Technology can be used to make it easier for patients and practices to participate in clinical trials, while also easing some of the burden on research staff, said James Hamrick, MD, MPH, Kaiser Permanente and Flatiron Health.
Technology can be used to make it easier for patients and practices to participate in clinical trials, while also easing some of the burden on research staff, said James Hamrick, MD, MPH, Kaiser Permanente and Flatiron Health.
Transcript
How is technology making it a little easier to enroll patients in clinical trials and manage these trials?
I think of technology as a tool that can make clinical trials a little bit less disruptive to the clinical workflow and a little bit less burdensome on the research staff. So an example: if you can design within your electronic medical record, a way that you can capture disease factors—think biomarkers, like EGFR or ROS or ALK in lung cancer—if you can capture those in structured data fields, then you can start to use that as a filter for screening patients for the trial. That makes the work of the research team significantly easier, because they don’t have to go through every patient who comes to the practice.
It also increases your hit rate, so you’re less likely to miss patients who are coming through your doors that could be a candidate for a trial if you have that automated safety net running in the background.
In addition, I think there’s a huge opportunity for technology to change the way we capture data in clinical trials. So, most trials, right now, there’s a duplicative data entry process. The patient comes in and is seen, there clinical care is documented as it normally would be, and then a research staff member has to go into an electronic data capture (EDC) format and reenter the data. Dual data entry is obviously burdensome and time consuming and slows things down. If you can have the EHR directly populate the EDC that would be transformative in getting really high-quality data in a really timely manner, which is what sponsors are looking for.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More